Consistent Hypofibrinogenemia Associated with Induction Anti-Tumor Chemotherapy for Acute Myeloid Leukemia.

被引：0
作者：
Elamil, Zeina G. [1 ]
Tuncer, Hande H. [1 ]
Tara, Roy [1 ]
Al Homsi, Samer A. [1 ]
机构：
[1] Roger Williams Med Ctr, Div Hematol Malignancies & Blood & Marrow Transpl, Providence, RI USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：602 / 602
页数：1
相关论文
共 50 条
[21]   Assessment of the presence and anti-tumor potential of tumor-infiltrating lymphocytes in patients with acute myeloid leukemia [J].
Wei, Liya ;
Wang, Zhenkun ;
Zhang, Zhuo ;
Li, Yinghua ;
Fan, Shengjin ;
Zhao, Yanqiu ;
Liu, Zhiyu ;
Ye, Xiangmei ;
Zhang, Fan ;
Yu, Yingying ;
Liu, Xiaolong ;
Cao, Fenglin ;
Zhou, Jin .
CANCER MANAGEMENT AND RESEARCH, 2019, 11 :3187-3196
[22]   MicroRNA signatures associated with cytogenetics and outcome in acute myeloid leukemia. [J].
Garzon, Ramiro ;
Volinia, Stefano ;
Liu, Chang G. ;
Pichiorri, Flavia ;
Palumbo, Tiziana ;
Fabbri, Muller ;
Cimmino, Amelia ;
Alder, Hansjuerg ;
Flomenberg, Neal ;
Coombes, Kevin R. ;
Calin, George A. ;
Andreeff, Michael ;
Croce, Carlo M. .
BLOOD, 2006, 108 (11) :49A-49A
[23]   Neutropenic fever prophylaxis during induction therapy for acute myeloid leukemia. [J].
Nabbout, Nassim H. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[24]   CHEMOTHERAPY OF ACUTE-LEUKEMIA FROM THE VIEWPOINT OF THE ACTION MECHANISM OF ANTI-TUMOR AGENTS [J].
NAKAMURA, T .
ACTA HAEMATOLOGICA JAPONICA, 1980, 43 (06) :1022-1033
[25]   Effect of karyotype abnormalities (including failure to obtain metaphases) on response to induction chemotherapy and survival in acute myeloid leukemia. [J].
Powles, R ;
Singhal, S ;
Treleaven, J ;
Swansbury, GJ ;
Min, T ;
Horton, C ;
Middleton, G ;
Eisen, T ;
Catovsky, D ;
Mehta, J .
BLOOD, 1996, 88 (10) :3364-3364
[26]   Prognostic significance of early peripheral blood blasts clearance following induction chemotherapy for adult acute myeloid leukemia. [J].
Pakkala, S ;
Winton, E ;
Langston, A ;
Heffner, LT ;
Khoury, HJ .
BLOOD, 2005, 106 (11) :236B-236B
[27]   Expression of CD25+ cell subsets after induction chemotherapy in adult patients with acute myeloid leukemia. [J].
Min, WS ;
Kim, HJ ;
Choi, Y ;
Kim, SY ;
Eom, KS ;
Kim, YJ ;
Lee, S ;
Min, CK ;
Lee, JW ;
Kim, CC .
BLOOD, 2005, 106 (11) :228B-228B
[28]   FLAIE (FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE) AS INDUCTION CHEMOTHERAPY OF ADULT ACUTE MYELOID LEUKEMIA. A PILOT STUDY REPORT [J].
Candoni, A. ;
Simeone, E. ;
Michelutti, A. ;
Damiani, D. ;
Russo, D. ;
Fanin, R. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 :123-123
[29]   Relevance of Wilms' tumor gene expression in childhood acute myeloid leukemia. [J].
Gruhn, B ;
Häfer, R ;
Voigt, A ;
Wittig, S ;
Zintl, F .
BLOOD, 2000, 96 (11) :190B-190B
[30]   Acute lymphoblastic leukemia at relapse in an adult with acute myeloid leukemia. [J].
Lounici, A ;
ConyMakhoul, P ;
Lacombe, F ;
Boiron, JM ;
Merlio, JP ;
Marit, G ;
Reiffers, J .
BLOOD, 1996, 88 (10) :3391-3391
12345